Merit Medical Acquires Assets of Radial Assist

Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired the assets of Radial Assist, which include the RAD BOARD(R), RAD BOARD(R)XTRA(TM), RAD TRAC(TM), and RAD REST(R) devices.

Financing for the $2.5 million transaction was provided by Wells Fargo Bank with an expansion of Merit's existing credit facility.

The RAD BOARD is designed to provide a larger work space for physicians and an area for patients to rest their arms during radial procedures.
The RAD BOARD XTRA is designed to work in conjunction with the RAD BOARD by extending the usable work space and allowing for a 90-degree perpendicular extension of the arm for physicians who prefer doing procedures at a 90-degree angle. The RAD TRAC is also designed to be used with the RAD BOARD and facilitates easy placement and removal of the RAD BOARD with the patient still on the table. The RAD REST is a disposable, single-use product designed to stabilize the arm by ergonomically supporting the elbow, forearm and wrist during radial procedures.

"We believe these products will assist us in our efforts to provide a complete offering for radial artery access procedures," said Fred P.
Lampropoulos, Merit's Chairman and CEO. "These products provide the necessary procedure set-up and enhance patient comfort."

CONFERENCE CALL

Merit will host a conference call to further discuss the details of this acquisition and the acquisition of the SAFEGUARD(R) Pressure Assisted Device and the AIR-BAND(TM) Radial Compression Device from Datascope Corp. today, October 7, 2013, at 4:00 p.m. Eastern (3:00 p.m.
Central, 2:00 p.m. Mountain, and 1:00 p.m. Pacific). The domestic phone number is (877) 941-9205 and the international number is (480) 629-9771. A live webcast as well as a rebroadcast of the conference call can be accessed through the Investors page at www.merit.com.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.